PMC:7796052 / 6173-6530 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":" for its repurposing as a therapeutic agent for the treatment of severe Covid-19.\n\n2. Results and Discussion\nIn order to have a preliminary insight into the affinity of ralixofene towards the bradykinin receptors, the compound was first tested at 20 µM for its capacity to displace a reference ligand from B1 and B2, respectively. Specifically, desArg10-kal","divisions":[{"label":"title","span":{"begin":83,"end":108}}],"tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"183","span":{"begin":72,"end":80},"obj":"Disease"},{"id":"195","span":{"begin":169,"end":179},"obj":"Chemical"}],"attributes":[{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:C000657245"},{"subj":"183","pred":"source","obj":"LitCovid-PubTator"},{"subj":"195","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T41","span":{"begin":83,"end":85},"obj":"Sentence"},{"id":"T42","span":{"begin":86,"end":108},"obj":"Sentence"},{"id":"T43","span":{"begin":109,"end":330},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T41","pred":"source","obj":"LitCovid-sentences"},{"subj":"T42","pred":"source","obj":"LitCovid-sentences"},{"subj":"T43","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ec93b0","default":true},{"id":"LitCovid-sentences","color":"#93caec"}]}]}}